Martin Auster
Stock Analyst at Raymond James
(4.52)
# 1,063
Out of 4,978 analysts
210
Total ratings
49%
Success rate
14.7%
Average return
Main Sectors:
Stocks Rated by Martin Auster
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASND Ascendis Pharma | Reiterated: Buy | $271 → $287 | $247.69 | +15.87% | 2 | Sep 15, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | $60 → $72 | $49.37 | +45.84% | 6 | Sep 14, 2026 | |
| EVMN Evommune | Reiterated: Buy | $40 → $18 | $9.37 | +92.10% | 3 | Sep 9, 2026 | |
| DYN Dyne Therapeutics | Reiterated: Buy | $40 | $17.31 | +131.15% | 5 | Aug 25, 2026 | |
| STTK Shattuck Labs | Initiated Coverage: Buy | $18 | $5.88 | +206.12% | 1 | Aug 24, 2026 | |
| SEPN Septerna | Rated: Buy | $53 → $49 | $38.44 | +27.47% | 3 | Aug 11, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $468 → $420 | $239.36 | +75.47% | 5 | Jul 31, 2026 | |
| PHAT Phathom Pharmaceuticals | Reiterated: Buy | $28 → $21 | $7.69 | +173.08% | 2 | Jul 31, 2026 | |
| IBIO iBio, Inc. | Initiated Coverage: Buy | $5 | $1.18 | +323.73% | 1 | Jun 8, 2026 | |
| EWTX Edgewise Therapeutics | Reiterated: Buy | $46 → $66 | $45.44 | +45.25% | 4 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $7 | $1.86 | +277.36% | 2 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $68.30 | - | 4 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 → $81 | $27.91 | +190.22% | 2 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $80 | $91.17 | -12.25% | 1 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 → $56 | $23.92 | +134.16% | 2 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $108 → $117 | $68.57 | +70.63% | 4 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $26 | $4.51 | +477.14% | 4 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $69.39 | n/a | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $6 | $54.16 | n/a | 3 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $102 → $100 | $64.73 | n/a | 14 | Oct 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $3.79 | n/a | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $12 | $24.53 | n/a | 2 | Mar 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $8 | $8.72 | n/a | 4 | Mar 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 → $58 | $27.91 | n/a | 6 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $156 → $72 | $19.76 | n/a | 23 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $169 → $196 | $498.48 | n/a | 17 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 → $98 | $1.76 | n/a | 5 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $64 → $99 | $12.88 | n/a | 15 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $60 | $122.58 | n/a | 17 | Jan 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $53 → $54 | $67.59 | n/a | 12 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 → $78 | $42.49 | n/a | 5 | Nov 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 → $12 | $4.17 | n/a | 9 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 → $24 | $11.49 | n/a | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $43 | $11.20 | n/a | 4 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $529.00 | n/a | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $14 | $27.17 | n/a | 4 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $54.31 | n/a | 8 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $16 → $4 | $0.0001 | n/a | 3 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $0.9906 | n/a | 1 | Jan 18, 2018 |
Ascendis Pharma
Sep 15, 2026
Reiterated: Buy
Price Target: $271 → $287
Current: $247.69
Upside: +15.87%
Scholar Rock Holding
Sep 14, 2026
Reiterated: Buy
Price Target: $60 → $72
Current: $49.37
Upside: +45.84%
Evommune
Sep 9, 2026
Reiterated: Buy
Price Target: $40 → $18
Current: $9.37
Upside: +92.10%
Dyne Therapeutics
Aug 25, 2026
Reiterated: Buy
Price Target: $40
Current: $17.31
Upside: +131.15%
Shattuck Labs
Aug 24, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $5.88
Upside: +206.12%
Septerna
Aug 11, 2026
Rated: Buy
Price Target: $53 → $49
Current: $38.44
Upside: +27.47%
Alnylam Pharmaceuticals
Jul 31, 2026
Reiterated: Buy
Price Target: $468 → $420
Current: $239.36
Upside: +75.47%
Phathom Pharmaceuticals
Jul 31, 2026
Reiterated: Buy
Price Target: $28 → $21
Current: $7.69
Upside: +173.08%
iBio, Inc.
Jun 8, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $1.18
Upside: +323.73%
Edgewise Therapeutics
Jun 1, 2026
Reiterated: Buy
Price Target: $46 → $66
Current: $45.44
Upside: +45.25%
May 28, 2026
Reiterated: Buy
Price Target: $6 → $7
Current: $1.86
Upside: +277.36%
May 26, 2026
Downgraded: Hold
Price Target: n/a
Current: $68.30
Upside: -
May 26, 2026
Reiterated: Buy
Price Target: $76 → $81
Current: $27.91
Upside: +190.22%
Apr 10, 2026
Initiated Coverage: Buy
Price Target: $80
Current: $91.17
Upside: -12.25%
Mar 25, 2026
Reiterated: Buy
Price Target: $48 → $56
Current: $23.92
Upside: +134.16%
Jan 13, 2026
Reiterated: Buy
Price Target: $108 → $117
Current: $68.57
Upside: +70.63%
Jan 13, 2026
Reiterated: Buy
Price Target: $21 → $26
Current: $4.51
Upside: +477.14%
Jul 30, 2025
Downgraded: Hold
Price Target: n/a
Current: $69.39
Upside: n/a
Nov 16, 2021
Reiterated: Buy
Price Target: $26 → $6
Current: $54.16
Upside: n/a
Oct 28, 2021
Reiterated: Buy
Price Target: $102 → $100
Current: $64.73
Upside: n/a
Mar 22, 2021
Initiated Coverage: Buy
Price Target: $26
Current: $3.79
Upside: n/a
Mar 16, 2021
Reiterated: Buy
Price Target: $29 → $12
Current: $24.53
Upside: n/a
Mar 16, 2021
Reiterated: Hold
Price Target: $7 → $8
Current: $8.72
Upside: n/a
Mar 10, 2021
Reiterated: Buy
Price Target: $49 → $58
Current: $27.91
Upside: n/a
Mar 2, 2021
Reiterated: Hold
Price Target: $156 → $72
Current: $19.76
Upside: n/a
Feb 22, 2021
Reiterated: Buy
Price Target: $169 → $196
Current: $498.48
Upside: n/a
Feb 11, 2021
Reiterated: Buy
Price Target: $62 → $98
Current: $1.76
Upside: n/a
Jan 25, 2021
Reiterated: Hold
Price Target: $64 → $99
Current: $12.88
Upside: n/a
Jan 19, 2021
Reiterated: Buy
Price Target: $50 → $60
Current: $122.58
Upside: n/a
Jan 11, 2021
Reiterated: Hold
Price Target: $53 → $54
Current: $67.59
Upside: n/a
Nov 20, 2020
Reiterated: Buy
Price Target: $76 → $78
Current: $42.49
Upside: n/a
Nov 6, 2020
Reiterated: Hold
Price Target: $11 → $12
Current: $4.17
Upside: n/a
Nov 5, 2020
Reiterated: Hold
Price Target: $21 → $24
Current: $11.49
Upside: n/a
Oct 8, 2020
Reiterated: Buy
Price Target: $27 → $43
Current: $11.20
Upside: n/a
Sep 23, 2020
Reiterated: Buy
Price Target: n/a
Current: $529.00
Upside: n/a
Sep 15, 2020
Reiterated: Sell
Price Target: $14
Current: $27.17
Upside: n/a
Jul 7, 2020
Reiterated: Hold
Price Target: $16
Current: $54.31
Upside: n/a
Nov 7, 2019
Downgraded: Hold
Price Target: $16 → $4
Current: $0.0001
Upside: n/a
Jan 18, 2018
Initiated Coverage: Buy
Price Target: $17
Current: $0.9906
Upside: n/a